The pharmacokinetics of YM150, an oral direct factor Xa inhibitor, exhibits dose proportionality with no clinically relevant effect of ethnicity or genderClin Pharmacol Therapeut - Groenendaal, D; Kadokura, T; Andersen, G (2011)
(Suppl 1): Abstract PIII-59.